Ferrari Beat Estimates. Stock Slump Explained for Investors
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...
Stock Market
This page features valuable insights into the Stock Market, covering topics like tariffs and dividend investing. Stay informed to enhance your investment strategies.
1,400 articles
Trump-Backed American Bitcoin Posts Record Loss Amid Mining Boom
American Bitcoin reports an $82 million Q1 loss even as it mines a record 817 BTC. Lower BTC prices and rising reserv...
This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Prediction: Where Palantir Stock Could Be in 5 Years
This article lays out a practical framework to think about where Palantir stock might head in five years. It blends r...
Visa Just Beat Earnings: The Bigger Story Investors Watch
When a payments giant tops the headline numbers, savvy investors look beyond the beat. This article breaks down why v...
A $500,000 Dividend Portfolio That Pays More Than Wage
As wage growth stalls for some workers, investors pursue dividend income. This piece examines how a $500,000 dividend...
NVIDIA: The Party Going, but How Much Longer for Investors?
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
April’s Jobs Report Crushes: Markets Weigh Mixed Signals
April’s jobs report beat expectations with a surprising payroll gain, yet revisions and sector gaps create a murkier ...
Best Casino Stocks Rally as U.S. Economy Rebounds in 2026
A new wave of gains in the best casino stocks tracks improving consumer sentiment and growth in online gaming. The se...
Mercadolibre Stock Crashed Today: Why the Drop Happened
Mercadolibre stock crashed today after investors digested a quarter that showed rising revenue but softer earnings. T...
Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Pfizer Stock: Still Priced — a Long-Term Opportunity for Investors
Pfizer's stock has lagged since 2021, but the story isn’t over. This guide breaks down why pfizer stock: still priced...